Lazard Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $524K | Buy |
9,542
+3,298
| +53% | +$181K | ﹤0.01% | 1481 |
|
|
2025
Q1 | $441K | Sell |
6,244
-4,003
| -39% | -$283K | ﹤0.01% | 1438 |
|
|
2024
Q4 | $673K | Buy |
10,247
+3,668
| +56% | +$241K | ﹤0.01% | 1283 |
|
|
2024
Q3 | $462K | Buy |
6,579
+6,323
| +2,470% | +$444K | ﹤0.01% | 1376 |
|
|
2024
Q2 | $20K | Sell |
256
-518
| -67% | -$40.5K | ﹤0.01% | 2019 |
|
|
2024
Q1 | $66K | Sell |
774
-212
| -22% | -$18.1K | ﹤0.01% | 1658 |
|
|
2023
Q4 | $94K | Buy |
986
+40
| +4% | +$3.81K | ﹤0.01% | 1680 |
|
|
2023
Q3 | $83K | Buy |
946
+42
| +5% | +$3.69K | ﹤0.01% | 1689 |
|
|
2023
Q2 | $78K | Sell |
904
-3,387
| -79% | -$292K | ﹤0.01% | 1672 |
|
|
2023
Q1 | $416K | Buy |
4,291
+3,511
| +450% | +$340K | ﹤0.01% | 1138 |
|
|
2022
Q4 | $80K | Sell |
780
-1,279
| -62% | -$131K | ﹤0.01% | 1609 |
|
|
2022
Q3 | $174K | Buy |
2,059
+1
| +0% | +$85 | ﹤0.01% | 1301 |
|
|
2022
Q2 | $169K | Buy |
2,058
+72
| +4% | +$5.91K | ﹤0.01% | 1327 |
|
|
2022
Q1 | $153K | Sell |
1,986
-331
| -14% | -$25.5K | ﹤0.01% | 1303 |
|
|
2021
Q4 | $204K | Buy |
2,317
+811
| +54% | +$71.4K | ﹤0.01% | 1272 |
|
|
2021
Q3 | $116K | Sell |
1,506
-569
| -27% | -$43.8K | ﹤0.01% | 1382 |
|
|
2021
Q2 | $172K | Sell |
2,075
-5,145
| -71% | -$426K | ﹤0.01% | 1237 |
|
|
2021
Q1 | $545K | Buy |
7,220
+7,186
| +21,135% | +$542K | ﹤0.01% | 965 |
|
|
2020
Q4 | $2K | Buy |
+34
| New | +$2K | ﹤0.01% | 1804 |
|
|
2020
Q2 | – | Sell |
-15,691
| Closed | -$1.33M | – | 1618 |
|
|
2020
Q1 | $1.33M | Buy |
15,691
+15,587
| +14,988% | +$1.32M | ﹤0.01% | 714 |
|
|
2019
Q4 | $8K | Buy |
+104
| New | +$8K | ﹤0.01% | 1400 |
|
|
2018
Q3 | – | Sell |
-18,427
| Closed | -$1.74M | – | 1048 |
|
|
2018
Q2 | $1.74M | Buy |
18,427
+10,836
| +143% | +$1.02M | ﹤0.01% | 675 |
|
|
2018
Q1 | $615K | Sell |
7,591
-1,727
| -19% | -$140K | ﹤0.01% | 756 |
|
|
2017
Q4 | $830K | Sell |
9,318
-3,417
| -27% | -$304K | ﹤0.01% | 715 |
|
|
2017
Q3 | $1.18M | Sell |
12,735
-3,940
| -24% | -$366K | ﹤0.01% | 667 |
|
|
2017
Q2 | $1.51M | Sell |
16,675
-3,426
| -17% | -$311K | ﹤0.01% | 636 |
|
|
2017
Q1 | $1.76M | Sell |
20,101
-10,847
| -35% | -$952K | ﹤0.01% | 665 |
|
|
2016
Q4 | $2.56M | Sell |
30,948
-12,433
| -29% | -$1.03M | 0.01% | 606 |
|
|
2016
Q3 | $4.01M | Buy |
43,381
+7,762
| +22% | +$718K | 0.01% | 552 |
|
|
2016
Q2 | $2.77M | Buy |
+35,619
| New | +$2.77M | 0.01% | 585 |
|
|
2014
Q3 | – | Sell |
-6,184
| Closed | -$384K | – | 1042 |
|
|
2014
Q2 | $384K | Buy |
+6,184
| New | +$384K | ﹤0.01% | 809 |
|